These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 973012)

  • 1. [Hormonal effects of carbidopa-levodopa in normal patients].
    Marti-Masso JF; Carrera N; Martinez-Lage JM
    Rev Clin Esp; 1976 Jul; 142(1):35-41. PubMed ID: 973012
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of carbidopa and L-dopa combination on the secretion of growth hormone in normal subjects and in patients with Parkinsonism].
    Nurzia A; Vacca U; Pirro R; Cerone G
    Clin Ter; 1975 Aug; 74(3):265-70. PubMed ID: 1227747
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of low dose carbidopa/levodopa on prolactin and growth hormone concentrations in patients with breast cancer and in benign breast tumours.
    Jones MK; Ramsay ID; Jenner PG
    Br J Clin Pharmacol; 1978 May; 5(5):425-30. PubMed ID: 656281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavior of plasma IRI, HGH and cortisol after administration of levodopa in patients with hepatic cirrhosis].
    Palazzuoli V; Gragnoli G; Favilli R; Tanganelli I; Migliarese G
    Boll Soc Ital Biol Sper; 1976 May; 52(9):630-5. PubMed ID: 949450
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of carbidopa on prolactin, growth hormone and cortisol secretion in man.
    Brown GM; Garfinkel PE; Warsh JJ; Stancer HC
    J Clin Endocrinol Metab; 1976 Jul; 43(1):236-9. PubMed ID: 947942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HGH secretion after oral application of L-dopa and L-carbidopa (author's transl)].
    Schönberger W; Ziegler R; Brodt B; Grimm W
    Eur J Pediatr; 1976 Jun; 122(3):195-200. PubMed ID: 1278188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carbidopa-levodopa, growth hormone and parkinsonism].
    Marti-Masso JF; Carrera N; Martínez-Lage JM
    Rev Clin Esp; 1976 Jun; 141(6):525-32. PubMed ID: 968087
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of Parkinson's disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa.
    Fermaglich J
    Med Ann Dist Columbia; 1974 Dec; 43(12):587-91. PubMed ID: 4532167
    [No Abstract]   [Full Text] [Related]  

  • 9. L-dopa stimulation of glucagon secretion in man.
    Rayfield EJ; George DT; Eichner HL; Hsu TH
    N Engl J Med; 1975 Sep; 293(12):589-91. PubMed ID: 1152893
    [No Abstract]   [Full Text] [Related]  

  • 10. [Stimulation of the secretion of somatotropin by administration of Nacom (L-dopa and L-carbidopa) in ambulatory patients with retarded growth].
    Schönberger W; Grimm W; Ziegler R; Brodt B
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):485-7. PubMed ID: 876212
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of L-dopa with and without decarboxylase inhibitor on growth hormone secretion in children with short stature.
    Fevang FO; Stoa RF; Thorsen T; Aarskog D
    Acta Paediatr Scand; 1977 Jan; 66(1):81-4. PubMed ID: 831384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism of hyperglycemia and stimulation of growth hormone secretion by L-dopa.
    Hampshire J; Moraru E; Altszuler N
    Pharmacology; 1978; 17(3):138-48. PubMed ID: 704657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the dopa decarboxylase inhibitor MK-486 on L-dopa-induced inhibition of prolactin secretion: evidence for CNS participation in the L-dopa effects.
    Szabo M; Nakawatase C; Kovathana N; Frohman LA
    Neuroendocrinology; 1977; 24(1):24-34. PubMed ID: 600362
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of L-dopa on the response of the hypothalamo-hypophyseal-adrenocortical system to insulin-induced hypoglycemia in normal and obese subjects].
    Bertolini S; Elicio N; Costa S; Balestreri R
    Boll Soc Ital Biol Sper; 1975 Feb; 51(4):189-95. PubMed ID: 1203116
    [No Abstract]   [Full Text] [Related]  

  • 15. [Disulfiram and inhibition by L-dopa of the hypothalamo-hypophyseal-adrenocortical system during hypoglycemic stress in humans].
    Bertolini S; Elicio N; Costa S; Balestreri R
    Boll Soc Ital Biol Sper; 1975 Feb; 51(4):184-8. PubMed ID: 1203115
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroendocrine function in schizophrenia.
    Brambilla F
    Acta Psychiatr Belg; 1980; 80(4):421-35. PubMed ID: 6792866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of alpha-methyldopa on the inhibition by L-dopa of the hypothalamo-hypophyseal-adrenocortical system during hypoglycemic stress in humans].
    Bertolini S; Elicio N; Costa S; Balestreri R
    Boll Soc Ital Biol Sper; 1975 Feb; 51(4):178-83. PubMed ID: 1203114
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of oral glucose load on the blood sugar and hormonal response during oral glucose tolerance tests over 5 hours in obese non-diabetic subjects].
    Eschwege E; Valleron AJ; Papoz L; Rosselin EG
    Ann Biol Clin (Paris); 1972; 30(3):225-32. PubMed ID: 5056533
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute effects of levodopa plus carbidopa on evoked potentials in Parkinson's disease.
    Cosi V; Romani A; Callieco R; Zerbi F
    Boll Soc Ital Biol Sper; 1984 Mar; 60(3):603-9. PubMed ID: 6712828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-dopa, growth hormone and adipokinesis in the lean and the obese.
    Pinter EJ; Tolis G; Friesen HG
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):277-80. PubMed ID: 1165135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.